Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study
Neuropsychopharmacology, Published online: 12 October 2026; doi:10.1038/s41386-026-02572-2 Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study
Andrea C. King, Rachel K. Nordgren, Dingcai Cao, Claire E. Wellendorf, Daniel J. Fridberg. Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study. // Neuropsychopharmacology. – 2026. – DOI: 10.1038/s41386-026-02572-2. – URL: https://www.nature.com/articles/s41386-026-02572-2
Andrea C. King, Rachel K. Nordgren, Dingcai Cao, Claire E. Wellendorf, & Daniel J. Fridberg (2026). Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study. Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02572-2
Andrea C. King, et al. “Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study.” Neuropsychopharmacology, 2026. doi:10.1038/s41386-026-02572-2.
@article{King2026,
title = {Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study},
author = {King, Andrea C. and Nordgren, Rachel K. and Cao, Dingcai and Wellendorf, Claire E. and Fridberg, Daniel J.},
journal = {Neuropsychopharmacology},
year = {2026},
doi = {10.1038/s41386-026-02572-2},
url = {https://www.nature.com/articles/s41386-026-02572-2}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...